
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer
Kimberly J. Cocce, Jeff S. Jasper, Taylor K. Desautels, et al.
Cell Reports (2019) Vol. 29, Iss. 4, pp. 889-903.e10
Open Access | Times Cited: 58
Kimberly J. Cocce, Jeff S. Jasper, Taylor K. Desautels, et al.
Cell Reports (2019) Vol. 29, Iss. 4, pp. 889-903.e10
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Overcoming Endocrine Resistance in Breast Cancer
Ariella B. Hanker, Dhivya R. Sudhan, Carlos L. Arteaga
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 496-513
Open Access | Times Cited: 653
Ariella B. Hanker, Dhivya R. Sudhan, Carlos L. Arteaga
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 496-513
Open Access | Times Cited: 653
Pioneering the developmental frontier
Elizabeth D. Larson, Audrey J. Marsh, Melissa M. Harrison
Molecular Cell (2021) Vol. 81, Iss. 8, pp. 1640-1650
Open Access | Times Cited: 62
Elizabeth D. Larson, Audrey J. Marsh, Melissa M. Harrison
Molecular Cell (2021) Vol. 81, Iss. 8, pp. 1640-1650
Open Access | Times Cited: 62
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 53
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 53
LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
Muqing Li, Mingyu Liu, Wanting Han, et al.
Cancer Research (2023) Vol. 83, Iss. 10, pp. 1684-1698
Open Access | Times Cited: 34
Muqing Li, Mingyu Liu, Wanting Han, et al.
Cancer Research (2023) Vol. 83, Iss. 10, pp. 1684-1698
Open Access | Times Cited: 34
The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition
Ayalur Raghu Subbalakshmi, Sarthak Sahoo, Prakruthi Manjunatha, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Ayalur Raghu Subbalakshmi, Sarthak Sahoo, Prakruthi Manjunatha, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 26
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Darcie D. Seachrist, Lindsey J. Anstine, Ruth A. Keri
Cancers (2021) Vol. 13, Iss. 20, pp. 5205-5205
Open Access | Times Cited: 51
Darcie D. Seachrist, Lindsey J. Anstine, Ruth A. Keri
Cancers (2021) Vol. 13, Iss. 20, pp. 5205-5205
Open Access | Times Cited: 51
GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer
Kohei Kumegawa, Yōko Takahashi, Sumito Saeki, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Kohei Kumegawa, Yōko Takahashi, Sumito Saeki, et al.
npj Breast Cancer (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Shiyi Yu, Ying Wang, Xue Gong, et al.
Cancer Research (2023) Vol. 83, Iss. 19, pp. 3220-3236
Closed Access | Times Cited: 19
Shiyi Yu, Ying Wang, Xue Gong, et al.
Cancer Research (2023) Vol. 83, Iss. 19, pp. 3220-3236
Closed Access | Times Cited: 19
Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response
Qingqing Qin, Ying Zhou, Jintao Guo, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Qingqing Qin, Ying Zhou, Jintao Guo, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
GRHL2-controlled gene expression networks in luminal breast cancer
Zi Wang, Bircan Coban, Haoyu Wu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Zi Wang, Bircan Coban, Haoyu Wu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer
Eneda Toska
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189097-189097
Open Access | Times Cited: 5
Eneda Toska
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 3, pp. 189097-189097
Open Access | Times Cited: 5
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells
Jason Kirk, Jie Wang, Mark D. Long, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1203-1221.e7
Open Access | Times Cited: 5
Jason Kirk, Jie Wang, Mark D. Long, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1203-1221.e7
Open Access | Times Cited: 5
The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor
Kaitlyn J. Andreano, Jennifer G. Baker, Sunghee Park, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 7, pp. 1395-1405
Open Access | Times Cited: 33
Kaitlyn J. Andreano, Jennifer G. Baker, Sunghee Park, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 7, pp. 1395-1405
Open Access | Times Cited: 33
Grainyhead-like (Grhl) Target Genes in Development and Cancer
Jemma G. Gasperoni, Jarrad N. Fuller, Charbel Darido, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2735-2735
Open Access | Times Cited: 21
Jemma G. Gasperoni, Jarrad N. Fuller, Charbel Darido, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2735-2735
Open Access | Times Cited: 21
Epigenetic reprogramming of a distal developmental enhancer cluster drivesSOX2overexpression in breast and lung adenocarcinoma
Luis E. Abatti, Patricia Lado-Fernández, Linh Huynh, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 19, pp. 10109-10131
Open Access | Times Cited: 11
Luis E. Abatti, Patricia Lado-Fernández, Linh Huynh, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 19, pp. 10109-10131
Open Access | Times Cited: 11
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines
Liying Yang, Kohei Kumegawa, Sumito Saeki, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 736-745
Open Access | Times Cited: 4
Liying Yang, Kohei Kumegawa, Sumito Saeki, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 5, pp. 736-745
Open Access | Times Cited: 4
GRHL and PGR control WNT4 expression in the mammary gland via 3D looping of conserved and species-specific enhancers
Yorick Bernardus Cornelis van de Grift, Marleen T. Aarts, Katrin E. Wiese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Yorick Bernardus Cornelis van de Grift, Marleen T. Aarts, Katrin E. Wiese, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Integrated Chromatin Accessibility and Transcriptome Landscapes of Doxorubicin-Resistant Breast Cancer Cells
Xuelong Wang, Jizhou Yan, Baiyong Shen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 27
Xuelong Wang, Jizhou Yan, Baiyong Shen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 27
Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens
Rui Lopes, Kathleen Sprouffske, Caibin Sheng, et al.
Science Advances (2021) Vol. 7, Iss. 27
Closed Access | Times Cited: 25
Rui Lopes, Kathleen Sprouffske, Caibin Sheng, et al.
Science Advances (2021) Vol. 7, Iss. 27
Closed Access | Times Cited: 25
AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer
Ke Zhang, Yuan Li, Xiangyi Kong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Ke Zhang, Yuan Li, Xiangyi Kong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer
H. Karimi Kinyamu, Brian D. Bennett, James M. Ward, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 1082-1099
Open Access | Times Cited: 3
H. Karimi Kinyamu, Brian D. Bennett, James M. Ward, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 1082-1099
Open Access | Times Cited: 3
Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
Michael D. Iglesia, Reyka G. Jayasinghe, Siqi Chen, et al.
Nature Cancer (2024) Vol. 5, Iss. 11, pp. 1713-1736
Open Access | Times Cited: 3
Michael D. Iglesia, Reyka G. Jayasinghe, Siqi Chen, et al.
Nature Cancer (2024) Vol. 5, Iss. 11, pp. 1713-1736
Open Access | Times Cited: 3
Grainyhead-like 2 as a double-edged sword in development and cancer.
Jiaxing He, Chunyang Feng, He Zhu, et al.
PubMed (2020) Vol. 12, Iss. 2, pp. 310-331
Closed Access | Times Cited: 26
Jiaxing He, Chunyang Feng, He Zhu, et al.
PubMed (2020) Vol. 12, Iss. 2, pp. 310-331
Closed Access | Times Cited: 26
Spotlight on the Granules (Grainyhead-Like Proteins) – From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape
Vignesh Sundararajan, Qing You Pang, Mahesh Choolani, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 24
Vignesh Sundararajan, Qing You Pang, Mahesh Choolani, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 24
Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression
Duojiao Chen, Taylor M. Parker, Poornima Bhat‐Nakshatri, et al.
Oncogene (2021) Vol. 40, Iss. 7, pp. 1332-1346
Open Access | Times Cited: 21
Duojiao Chen, Taylor M. Parker, Poornima Bhat‐Nakshatri, et al.
Oncogene (2021) Vol. 40, Iss. 7, pp. 1332-1346
Open Access | Times Cited: 21